hope in the end both are successful. If the other knocks it out of the park and broad application and low side effects then sobeit.
I am happy to see pyc adding to their platform with potentially effective solutions.
Sooner or later these Ann will shoot the lights out and sp reflects the progress being made.
Ann: PMS Drug Candidate Effective In Human Brain Cells, page-9
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $956.5M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 19.3¢ | $758.0K | 3.815M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 59988 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 589881 | 5 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| PYC (ASX) Chart |